🇫🇷 SUGEMALIMAB in France

SUGEMALIMAB (SUGEMALIMAB) regulatory status in France.

Marketing authorisation

ANSM

  • Local brand name: Cejemly
  • Status: approved

SUGEMALIMAB in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in France

Frequently asked questions

Is SUGEMALIMAB approved in France?

Yes. ANSM has authorised it.

Who is the marketing authorisation holder for SUGEMALIMAB in France?

Marketing authorisation holder not available in our data.